No price history available.
Key financial summary
Financials in BRL| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | BRLm | 36,922 | 40,165 | 29,224 | 19,831 | 24,090 | 21,823 | N/A | N/A |
| Operating profit | BRLm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | BRLm | -650 | 1,048 | -2,860 | 2,975 | -8,930 | -1,785 | N/A | N/A |
| EPS reported | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | BRLm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | BRLm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | BRLm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | BRL | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in BRL| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Natura & Co Holding S.A. is a prominent entity in the beauty and personal care industry, specializing in the creation, production, and worldwide sale of cosmetics, fragrances, and hygiene products. The company offers an extensive selection, including items for body and facial care, makeup, soaps, hair treatments, deodorants, various oils, men's grooming essentials, and sun protection solutions. These products are marketed under a portfolio of renowned brands, notably Natura, Aesop, Avon, and The Body Shop. Natura & Co employs a diverse distribution strategy, reaching customers through signature retail outlets, department stores, online platforms, direct selling networks, business-to-business collaborations, and franchise operations. Its market presence spans across major global regions, including Asia, North and South America, Europe, the Middle East, Africa, and Oceania. Established in 1969, the company's corporate headquarters are situated in São Paulo, Brazil.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Natura & Co Holding S.A. (NATU3.SA)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Natura & Co Holding S.A. is a prominent entity in the beauty and personal care industry, specializing in the creation, production, and worldwide sale of cosmetics, fragrances, and hygiene products. The company offers an extensive selection, including items for body and facial care, makeup, soaps, hair treatments, deodorants, various oils, men's grooming essentials, and sun protection solutions. These products are marketed under a portfolio of renowned brands, notably Natura, Aesop, Avon, and The Body Shop. Natura & Co employs a diverse distribution strategy, reaching customers through signature retail outlets, department stores, online platforms, direct selling networks, business-to-business collaborations, and franchise operations. Its market presence spans across major global regions, including Asia, North and South America, Europe, the Middle East, Africa, and Oceania. Established in 1969, the company's corporate headquarters are situated in São Paulo, Brazil.